JB Chemicals gets USFDA nod to market generic medication
J B Chemicals & Pharmaceuticals, a Rs. 3,100 crore plus pharma major, has posted strong performance during the first quarter ended June 2023 and its consolidated net profit increased by 35.2 per cent to Rs. 142 crore from Rs. 105 crore in the corresponding period of last year. EBITDA touched to Rs, 232 crore as compared to Rs. 173 crore. Its revenues went up by 14 per cent to Rs. 896 crore from Rs. 785 crore. EPS moved up to Rs. 18.39 from Rs. 13.59 in the last period.
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed. Earlier, the board of directors of J. B. Chemicals & Pharmaceuticals had given approval for acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited.
Mumbai: J B Chemicals & Pharmaceuticals published its inaugural Sustainability(ESG) report which reflects the company's commitment to cascading practices across all operations responsible and fostering transparency regarding the company’s progress in its ESG objectives. The report is prepared following the international reporting standards framework, the Global Reporting Initiative (GRI) as its Core Standard, and linkages with the Sustainable Development Goals (SDGs).
JB Chemicals & Pharmaceuticals on Thursday said its board has approved a proposal to acquire four pediatric brands from Dr Reddy’s Laboratories for about Rs 98 crore.
Torrent Pharmaceuticals and KKR-controlled JB Chemicals are among the final contenders to acquire Chennai-based Curatio Healthcare for about ?2,500 crore in what could be the continuation of M&A deals in the pharma and life sciences space.
Torrent Pharmaceuticals and KKR-controlled JB Chemicals are among the final contenders to acquire Chennai-based Curatio Healthcare for about ?2,500 crore in what could be the continuation of M&A deals in the pharma and life sciences space.
Six pharmaceutical majors Aurobindo, Biocon, Dr Reddy's, JB Chemicals, Torrent Pharma and Zydus Healthcare have been shortlisted for the acquisition of Curatio Healthcare, the Chennai-based company focused on skincare products, multiple people aware of the development, said.
JB Chemicals & Pharmaceuticals Limited (JBCPL), one of the fastest growing pharmaceutical companies in India, has announced that it will acquire brands for the Indian market from Sanzyme Private Limited (Sanzyme), a leading player in the probiotics and reproductive health segment in the country.
J B Chemicals & Pharmaceuticals Limited (JBCPL), one of the fastest growing pharmaceutical companies in India, recorded revenue of Rs. 606 crore for the first quarter ended 30th June, 2021, as compared to Rs. 522.3 crore, registering growth of 16 per cent over the corresponding quarter ended 30th June, 2020.